(Q34322964)
Statements
A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia (English)
George M Haig
Earle Bain
Weining Robieson
Jeffrey Baker
10 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference